The United States is a key contributor to the inactivated vaccines market, supported by its advanced healthcare infrastructure, strong immunization programs, and significant investments in vaccine research and development. The presence of leading pharmaceutical companies, growing focus on infectious disease prevention, and increasing adoption of adult vaccination programs continue to drive...